Kuhusu Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Source: Wikipedia
Makao makuu251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Ilianzishwa2018
HaliAmilifu

HatazaHataza 1

GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019

Tafuta hataza zote kwenye Heelky →

Mapitio

Bado hakuna mapitio. Umefanya kazi na Assertio Therapeutics, Inc.? Kuwa wa kwanza kushiriki uzoefu wako.

Andika pitio →

Mahali

251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US

Je, hii ni kampuni yako?

Dai ukurasa huu bure kuongeza nembo, bidhaa, picha na kazi zako, na kujibu mapitio.

Dai ukurasa huu

Shiriki kampuni hii

Assertio Therapeutics, Inc.251 LITTLE FALLS DRIVE, 19808, WILMINGTON, UShttps://heelky.com/explore/companies/assertio-therapeutics-inc-ur37rgl2/

Nakili kiungo

Shiriki kwenye

Msimbo wa QR

Uchanganue kwa kamera ya simu ili kufungua ukurasa huu, au uupakue kwa ajili ya kipeperushi, slaidi au beji.

Jiunge na Heelky kuunganisha, kuajiri na kukua

Unda akaunti ya bure kutuma ujumbe kwa watu, kuomba kazi na kuchapisha misheni.

Jiunge sasa — ni bure

Chagua lugha yako

Heelky itakumbuka chaguo lako.

Lugha nyingine

Lugha zinazopatikana: 70 Kuhusu lugha kwenye Heelky